Fasciolosis: pathogenesis, host-parasite interactions, and implication in vaccine development

Area of Science:

• Veterinary Parasitology
• Zoonotic Disease Research
• Vaccine Development

Background:

• Fasciola hepatica infection, or fasciolosis, is a global veterinary and emerging human health concern, leading to substantial economic losses in livestock.
• Current disease control relies on anthelmintics, but widespread resistance to drugs like triclabendazole is a growing problem.
• Concerns regarding drug residues in food and the environment further drive the need for alternative control strategies, particularly vaccines.

Purpose of the Study:

• To review current knowledge on host-parasite interactions in Fasciola hepatica infections.
• To discuss the implications of these interactions for the development of effective vaccines.
• To highlight the role of emerging technologies in advancing our understanding of Fasciola hepatica and vaccine design.

Main Methods:

• Literature review of existing research on Fasciola hepatica.
• Analysis of host-parasite interactions and their impact on immune responses.
• Examination of challenges and advancements in vaccine development for fasciolosis.

Main Results:

• Fasciola hepatica possesses potent immunomodulatory mechanisms that hinder effective host immune responses in susceptible species like ruminants.
• Despite extensive research, no vaccine candidate has achieved consistent and reproducible protection in target animals.
• Emerging technologies are generating more data on host-parasite interactions, crucial for rational vaccine design.

Conclusions:

• A comprehensive understanding of host-parasite interactions is essential for overcoming the challenges in Fasciola hepatica vaccine development.
• Addressing the parasite's immunomodulation is key to designing vaccines that elicit protective immunity.
• Continued research integrating new technologies is vital for advancing vaccine strategies against fasciolosis.